Pathology · Female Genital and Breast Pathology

Sertoli-Leydig cell tumor (arrhenoblastoma) of the ovary is associated with virilization. Which immunohistochemical marker, in addition to inhibin, is characteristically positive in this sex cord-stromal tumor?

  • A EMA (epithelial membrane antigen)
  • B WT1 (Wilms tumor protein 1)
  • C Calretinin
  • D PLAP (placental alkaline phosphatase)
Correct answer: C. Calretinin

Explanation

Sertoli-Leydig cell tumors, like other sex cord-stromal tumors (granulosa cell tumors, thecomas, fibromas), express inhibin and calretinin — both derived from the calretinin-positive sex cord stromal cells. The inhibin/calretinin combination is the key immunohistochemical panel to distinguish sex cord-stromal tumors from surface epithelial tumors (which are EMA+, CK7+) and germ cell tumors (PLAP+, OCT4+, SALL4+). WT1 is expressed in ovarian surface epithelial carcinomas (serous) and is not a marker of sex cord-stromal tumors.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Female Genital and Breast Pathology MCQs

See all Female Genital and Breast Pathology MCQs →